Summit Therapeutics SMMT
NASDAQ SMMT
$15.55 -0.28 (-1.77%)
At close: Oct 22, 2026 · 4:00 PM EDT

Summit Therapeutics (SMMT) Long-Term Debt Issuances (2021 - 2022)

Updated

Summit Therapeutics' Long-Term Debt Issuances came in at $520 million for Q4 2022.

Analysis

Summit Therapeutics (SMMT) Long-Term Debt Issuances (2021 - 2022) Analysis & Trends

For FY2022, Summit Therapeutics' Long-Term Debt Issuances was $545 million, up 395.5% from FY2021.

  • Long-Term Debt Issuances carries a five-year compound annual growth rate of 607.3% (FY2017 to FY2022).
  • Going back by year, Long-Term Debt Issuances was $110 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 8.94 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn -
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn -
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn -
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 1.98 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn -
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn -
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn -
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn -
10 Summit Therapeutics 12.33 Bn 10.09 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 520.00 Mn
Mar 31, 2022 25.00 Mn
Jun 30, 2021 55.00 Mn
Mar 31, 2021 55.00 Mn
API Access

Summit Therapeutics Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=SMMT&period=max&api_key=YOUR_API_KEY